Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Your RPS

RPS expresses alarm and fear after funding cut proposals emerge

Sandra Gidley, chair of the RPS English Pharmacy Board

Source: MAG / The Pharmaceutical Journal

“We fear for patients, the public and pharmacists who may be significantly affected by changes in opening hours and staffing levels in community pharmacy, as well as the knock on impact on already pressured GP and A&E NHS care,” says Sandra Gidley, chair of the RPS English Pharmacy board

The Royal Pharmaceutical Society (RPS) has said that it is “deeply disappointed” and “alarmed” it emerged that the Department of Health (DH) plans to cut community pharmacy funding in England by 12% from December 2016, with a further 7% cut due in 2017. 

The comments follow a statement from the Pharmaceutical Services Negotiating Committee (PSNC) issued on 14 October 2016 stating its decision to reject the DH’s proposed 2016–2017 funding package for the sector.

“Funding cuts will not improve the quality of care for patients delivered through community pharmacy,” says Sandra Gidley, chair of the RPS English Pharmacy Board. “Pharmacists will not be reassured by this two-year deal which guarantees less resource for front-line care. We fear for patients, the public and pharmacists who may be significantly affected by changes in opening hours and staffing levels in community pharmacy, as well as the knock on impact on already pressured GP and A&E NHS care.”

Gidley also deemed plans for a pilot of a NHS emergency medicines supply scheme, which was announced by the DH on 13 October 2016, as completely unnecessary.

“The NHS emergency medicines supply service is already tried and tested, with fantastic results that have both improved patient care and freed up time for GPs,” she says. “There is absolutely no need for further piloting of a service that is badly needed as we head towards winter. This needs to be implemented across England without further delay.”

Further proposals announced by the DH were around the integration of pharmacy into NHS 111. However, no details on how either proposal would be funded, or how the Pharmacy Integration Fund (PhIF) will be used, have been put in the public domain.

The PhIF was first proposed as part of the government’s plans for the community pharmacy sector in December 2015.

“The lack of news on the promised Pharmacy Integration Fund defies logic at a time when greater integration of primary care services to improve patient care is such a priority for the NHS,” says Gidley. “We call on the government to make good on its promise ‘to bring pharmacy even closer into the wider primary care and community health system’, so we can see improved patient care through better use of pharmacists in care homes and urgent and emergency care in the years to come.

“We also need assurance that the Government is serious about a national NHS funded minor ailments scheme through pharmacy,” she adds. 

The RPS says that it will continue to support its members through ”the difficult time ahead” and highlights that it has built stronger links with patient groups, local government and NHS England since the cuts were originally announced in December 2015. 

“We have not lost focus on our strategic aim to gain a commitment from Government and NHS England that community pharmacy and pharmacists are integral to the future plan for the NHS,” assures Gidley.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201839

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Sandra Gidley, chair of the RPS English Pharmacy Board

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.